SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-041027
Filing Date
2019-11-06
Accepted
2019-11-06 16:15:38
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20191106.htm   iXBRL 8-K 33056
2 EX-99.1 dvax-ex991_15.htm EX-99.1 269351
3 GRAPHIC govpgwxdamy3000001.jpg GRAPHIC 2228
  Complete submission text file 0001564590-19-041027.txt   449538

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dvax-20191106.xsd EX-101.SCH 5964
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20191106_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20191106_pre.xml EX-101.PRE 11627
8 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8k_20191106_htm.xml XML 3549
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 191196479
SIC: 2834 Pharmaceutical Preparations